HOOKIPA Pharma Promotes Katia Schlienger As Chief Medical Officer

RTTNews | il y a 747
HOOKIPA Pharma Promotes Katia Schlienger As Chief Medical Officer

(RTTNews) - Biopharmaceutical company HOOKIPA Pharma Inc. (HOOK) announced Thursday the promotion of Katia Schlienger, to Chief Medical Officer and the appointment of Malte Peters, to its Board of Directors, both effective January 1, 2023.

Schlienger, who joined the Company in 2021, has been promoted to Chief Medical Officer. She has served as the Company's Executive Vice President, Clinical Research and Development since July 2022. Prior to that, she served as Senior Vice President, Head of Immuno-Oncology Clinical Research and Development from January 2021 to June 2022.

Schlienger previously worked at Merck & Co., for 14 years, serving in roles of increasing responsibility across early and late-stage clinical development in oncology and vaccines.

Meanwhile, Peters serves as Chief Research and Development Officer at MorphoSys and will retire from the company at the end of 2022. He joined MorphoSys in 2017 as Chief Development Officer.

Prior to joining MorpoSys, Peters was Global Head of Clinical Development of the biopharmaceuticals business unit of Sandoz in Germany. He also spent 12 years in leadership positions at Novartis Oncology. Earlier in his career, he held positions at Micromet AG and Merck KgaA, and also served as a research scientist in infectious disease.

read more
TSX Ends Final Session Of 2024 On Firm Note, Posts Yearly Gain Of 18%

TSX Ends Final Session Of 2024 On Firm Note, Posts Yearly Gain Of 18%

The Canadian market ended on a firm note on Tuesday, the final session of 2024, as energy and materials stocks moved higher on firm commodity prices. Shares from real estate and communications sectors were the other notable gainers in the session.
RTTNews | il y a 6h 24min
Dollar Extends Gains Against Major Counterparts

Dollar Extends Gains Against Major Counterparts

The U.S. dollar gained against its major counterparts on Tuesday, the final session of Year 2024, on strong year-end demand and amid bets the Federal Reserve will take a cautious approach with regard to interest rate cuts as economic policies under the upcoming Trump administration will likely stoke inflation.
RTTNews | il y a 7h 6min
U.S. Dollar Strengthens Against Majors

U.S. Dollar Strengthens Against Majors

The U.S. dollar advanced against its major counterparts in the New York session on Tuesday amid indications of a hawkish Federal Reserve heading into 2025.
RTTNews | il y a 9h 23min
European Stocks Close Higher

European Stocks Close Higher

uropean stocks closed a shortened trading session on Tuesday on a positive note with investors largely making cautious moves amid a lack of prominent triggers. he markets in Germany and Switzerland remained closed for Christmas Eve.
RTTNews | il y a 13h 47min
Elon Musk Changes X Account Name To Kekius Maximus

Elon Musk Changes X Account Name To Kekius Maximus

Billionaire Elon Musk has changed his name on his social media platform X, formerly Twitter, to Kekius Maximus. His profile picture has also been replaced with the popular meme Pepe the Frog, dressed up as a warrior holding a video game joystick. In a post on X, Musk said, "Kekius Maximus will soon reach level 80 in hardcore PoE."
RTTNews | il y a 14h 39min
Canadian Stocks Likely To Open Higher

Canadian Stocks Likely To Open Higher

Higher Canadian and U.S, futures, and fairly steady commodity prices point to a positive start on Bay Street on Tuesday, the final trading session of 2024. Worries about the outlook for interest rates, and concerns over tariff threats by U.S. President-elect Donald Trump may limit market's upside.
RTTNews | il y a 15h 37min